Showing results (151-160 of 187) with videos related to

Sort By:
Pageof 19
Frontiers in Immunology|February 20, 2026
T cell and monocyte activation in concert with hematopoietic stem cell interactions shapes the post-allogeneic transplant immune landscape in poor graft functionAshvind Prabahran, Zhijie Wu, Shouguo Gao, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 31, 2020
Australasian Trends in Allogeneic Stem Cell Transplantation for Myelofibrosis in the Molecular Era: A Retrospective Analysis from the Australasian Bone Marrow Transplant Recipient RegistryYadanar Lwin, Glenn Kennedy, David Gottlieb, et al.
Molecular Oncology|January 16, 2026
European Code Against Cancer, 5th edition - cancer-causing infections and related interventionsCatharina Johanna Alberts, Paul Bloem, Silvia de Sanjosé, et al.
Molecular Oncology|January 16, 2026
European Code Against Cancer, 5th edition - tobacco and nicotine containing products, second-hand smoke, alcohol and cancerAriadna Feliu, Annie S Anderson, Linda Bauld, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|August 28, 2021
Dynamics of Epstein-Barr virus on post-transplant lymphoproliferative disorders after antithymocyte globulin-conditioned allogeneic hematopoietic cell transplantJulian Lindsay, Jad Othman, Michelle K Yong, et al.
Molecular Oncology|January 16, 2026
European Code Against Cancer, 5th edition - diet, excess body weight, physical activity, sedentary behavior, breastfeeding, and cancerMichael F Leitzmann, Ioanna Bakogianni, Annie S Anderson, et al.
JMIR Formative Research|September 19, 2025
Assessing the User Experience of the EU Mobile App for Cancer Prevention: Mixed Methods StudyFurqan Ahmed, Silvana Romero Saletti, Erica D'Souza, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2023
A Phase Ib/II Trial of Combined BRAF and EGFR Inhibition in BRAF V600E Positive Metastatic Colorectal Cancer and Other Cancers: The EVICT (Erlotinib and Vemurafenib In Combination Trial) StudyLavinia Tan, Ben Tran, Jeanne Tie, et al.
International Journal of Cancer|January 24, 2020
Key issues that need to be considered while revising the current annex of the European Council Recommendation (2003) on cancer screeningAntonio Ponti, Partha Basu, David Ritchie, et al.
Blood Advances|December 11, 2025
Venetoclax and ibrutinib induces durable clinical responses in marginal zone lymphomaSasanka M Handunnetti, Amit Khot, Piers Blombery, et al.
Pageof 19